“Injectable Drug Delivery Market”
Recent Developments in the Industry: # In 2016, Gerresheimer extended its partnership with Taisei Medical Co. Ltd. (Japan) with an aim to market its ...
The Injectable Drug Delivery Market is projected to reach USD 902.3 billion by 2027 from USD 362.38 billion in 2016, at a CAGR of 11.5% during the forecast ...
Growth in this market is mainly driven by increasing prevalence of chronic diseases, rising aging population, increasing use of biologics, and increasing ...
Growth in Injectable Drug Delivery Market is mainly driven by increasing prevalence of chronic diseases, rising aging population, increasing use of biologics, ...
Injectable Drug Delivery Market is Expected to Generate the Revenue worth 624.50 Billion USD by 2021
Growth in this market is mainly driven by increasing prevalence of chronic diseases, rising aging population, increasing use of biologics, and increasing ...
Drug delivery is the process of administering a pharmaceutical compound into the body through various routes to achieve a therapeutic effect. Oral, ...
Growth in this market is mainly driven by increasing prevalence of chronic diseases, rising aging population, increasing use of biologics, and increasing ...
The injectable drug delivery market is segmented based on type, formulation packaging, therapeutic application, usage pattern, site of administration, ...
